首页|斜外侧腰椎间融合术联合脊柱内固定融合系统治疗邻椎病的临床疗效分析

斜外侧腰椎间融合术联合脊柱内固定融合系统治疗邻椎病的临床疗效分析

扫码查看
目的:探讨斜外侧腰椎间融合术(OLIF)联合脊柱内固定融合系统(PIVOX系统)治疗邻椎病的临床疗效。方法:回顾性分析2018年10月至2022年10月,接受斜外侧腰椎间融合术联合PIVOX系统治疗的3 7例腰椎退变性并发相邻椎体病变患者的治疗效果。记录了手术时间、术中出血量、椎间隙高度、椎间孔面积、椎管面积、下腰痛视觉模拟量表(VAS)评分和患者Oswestry功能障碍指数(ODI)评分。结果:共37例患者,其中32个单节段病灶和5个双节段病灶。全部患者随访12~17个月,平均为(13。4±1。5)个月。术后椎间隙高度、椎间孔面积和椎管面积与术前相比差异有统计学意义(P<0。05);VAS评分从平均值(6。0±1。1)分降低到(2。3±0。5)分,ODI评分从60。4%±5。1%降至27。0%±8。1%,术后与术前相比差异有统计学意义(P<0。05)。结论:斜外侧腰椎间融合术联合脊柱斜外侧内固定融合系统(PIVOX)治疗效果显著,创伤小,并发症少,是一种安全、有效的方法,值得临床推广应用。
Clinical Efficacy Analysis of Oblique Lateral Lumbar Interbody Fusion Combined with Spinal Internal Fixation Fusion System in the Treatment of Adjacent Vertebral Diseases
Objective:To explore the clinical efficacy of oblique lateral lumbar interbody fusion(OLIF)combined with spi-nal fixation and fusion system(PIVOX system)in the treatment of adjacent spondylosis.Methods:From October 2018 to October 2022,37 cases of lumbar degeneration complicated with adjacent vertebral lesions were treated by OLIF combined with PIVOX system.The operation time,intraoperative blood loss,intervertebral space height,intervertebral foramen are-a,spinal canal area,visual analogue scale(VAS)scores of low back pain and Oswestry dysfunction index(ODI)were recorded.Results:There were 37 patients,including 32 single-segmental lesions and 5 double-segmental lesions.All pa-tients were followed up for 12-17 months,with an average of(13.4±1.5)months.The height of intervertebral space,in-tervertebral foramen area and spinal canal area after operation were significantly different from those before operation(P<0.05).Conclusion:OLIF combined with oblique lateral spinal internal fixation system(PIVOX system)is a safe and effective method with less trauma and less complications,and should be widely used in clinic.

spinal fusionspinal fixation and fusion systemadjacent spondylosis

潘瑞杰、谢添

展开 >

湖北中医药大学针灸骨伤学院(武汉,430061)

武汉市中医医院

脊柱融合 脊柱内固定融合系统 邻椎病

湖北省中医药局中医药重点项目(2023-2024)

ZY2023Z011

2024

中国中医骨伤科杂志
中华中医药学会,湖北省中医药研究院

中国中医骨伤科杂志

CSTPCD
影响因子:0.732
ISSN:1005-0205
年,卷(期):2024.32(3)
  • 19